A lack of patient images in atopic dermatitis clinical trial publications may hinder patients from participating in treatment decision-making, according to a recent systematic review published by Polesie and Alsterholm in the Journal of Dermatological Treatment. Images depicting disease severity prior to and following treatment may be more meaningful to patients compared with tabulated data and graphs. In the review, the investigators used the MEDLINE database from inception to December 21, 2023, to identify 60 prospective, randomized, controlled trials involving nearly 18,000 patients with atopic dermatitis who received systemic treatments. The goal of the analysis was to determine the frequency of clinical images available in published atopic dermatitis research. Among these trials, just 16 images representing six patients were published in the research. They noted that the share rate was 0.3 per 1,000. The investigators emphasized that including more images in these publications could enhance patients’ understanding of potential treatment outcomes and how atopic dermatitis may present in those with darker skin tones. In a companion press release on the findings from the University of Gothenburg, the study authors concluded: “We need more images of patients as visual aids in communication. It is difficult for patients to understand the figures used in scientific publications to describe severity or the effect a certain treatment may have.”